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ABSTRACT 
Curcumin is a substance that contained in turmeric yellow pigment. 
Curcumin has several benefits, which can be used as anti-bacterial, anti-
inflammatory, anti-oxidant and anti-neoplastic .But, the curcumin 
characteristic has poor water solubility and low bioavailability. The low 
bioavailability of curcumin certainly minimizes its therapeutical effects. This 
problem can be overcome by the application of mesoporous silica 
nanoparticle as a drug delivery system. 
Several research which has been conducted, by using mesoporous 
silica nanoparticles (MSN) as a drug carrier. These studies proved that MSN 
could maximize drug delivery process. The mechanism was by maintaining 
drug into a smaller size through encapsulation within the porous structure of 
MSN to improve drug delivery process in human body. However most of 
these studies used  mesoporous silica pore structure with 2D mesostructure. 
In this research, we use mesoporous silica nanoparticles (MSN) type 
IBN-2 which has 3D pore structure to overcome pore blocking issue, as a 
result of blockage of drug particles which were loaded into mesoporous 
silica. MSN is modified with alginate. The alginate is used to give effect of a 
controlled release at certain pH. Alginate is an anionic polymer, and has 
negative surface charge. Therefore, MSN is first coated with APTES to 
change the surface charge which also tend to be negative, so the alginate 
coating process runs optimally. Before that curcumin is loaded into the MSN, 
and then the alginate coating process is conducted. 
This research is conducted by varying the effect of APTES 
concentration, alginate concentration, and in-vitro release pH in various 
concentrations according to pH conditions in the human body. The synthesis 
are followed by various analysis using Spectrophotometer UV-Vis, and 
 xi 
 
Fourier Transform Infrared Spectroscopy to determine the characteristic of 
drug carriers. The purpose of  this research is to determine the optimum 
concentration and condition of mesoporous silica to improve the 
effectiveness of drug delivery process in specific area. Sample with ratio of 
MSN and APTES 1.2 mg : 3.0 ml with concentration of alginate 1 mg/ml 
showed better function of controlled release in certain pH.  
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